WPF urges FTC to focus on consumers’ ability to control their digital exhaust and statistical parity for big data era At the FTC workshop on Big Data September 15, Big Data: Tool for Inclusion or Exclusion?, panelists including the World Privacy Forum discussed legal and ethical frameworks that are applicable to large datasets and issues
Big Data and its potential for inclusion and exclusion was on center stage this past September as the FTC held a day-long workshop with experts from industry, technology, privacy, civil liberties, and academia. World Privacy Forum’s Executive Director Pam Dixon, a panelist at the event, spoke about Big Data and privacy, emphasizing several key points, including the need for statistical parity, fairness, and the need for keeping existing consumer protection regulation.
The World Privacy Forum filed comments with the U.S. Department of Commerce in response to its Request for Comments about big data, privacy, and the Consumer Privacy Bill of Rights. The White House Big Data report recognized that Big Data “raises considerable questions about how our framework for privacy protection applies in a big data ecosystem” and has the potential to “eclipse longstanding civil rights protections in how personal information is used in housing, credit, employment, health, education, and the marketplace.” This is among our concerns as well, and our comments focused on understanding big data’s benefits while drawing attention to where there are significant privacy risks that need to be addressed.
The World Privacy Forum’s recent public comments to the White House regarding Big Data focus on using a foundation of Fair Information Principles to address issues connected to bias, error, and privacy regarding big data as applied to vulnerable populations. The comments also discuss large medical research data sets, and stress the importance of applying
WPF filed comments with the Presidential Commission for the Study of Bioethics today urging the Commission to recognize the need for enhanced genetic privacy protections in a digital world. WPF noted that “The increasing identifiability of genetic data presents major privacy issues for research activities that must be acknowledged and addressed.” WPF suggested four key ways that Certificate of Confidentiality programs could be enhanced for privacy protection, and urged the Commission to speak out about the importance of protecting patient privacy in research activities involving genetic information. “The Commission should advocate providing patients with reasonable controls over research uses of their data as electronic records develop and spread throughout the health care system.” Public comments may be submitted to the Commission until May 25, 2012.